化学
体内分布
体内
酪氨酸
乙酰胺
部分
体外
结合
化学合成
组合化学
立体化学
氯贝特酸
甲状腺
铅化合物
生物活性
结构-活动关系
生物化学
药代动力学
甲酰胺
氨基酸
化学稳定性
配体(生物化学)
作者
Weiqi Liu,Minhao Liang,Taiwei Chu
标识
DOI:10.1021/acs.jmedchem.6c02347
摘要
Radioiodinated drugs face limited application due to severe in vivo deiodination. In this study, nine tyrosine derivatives were synthesized and evaluated to develop stable radioiodinated prosthetic groups to reduce deiodination. Biodistribution results revealed that replacing phenolic hydroxyl and amino groups with methoxy and acetamide groups enhanced stability. Compound 131I-8 exhibited the highest stability, with a maximum thyroid uptake of 1.13 ± 0.12 %ID (approximately one-20th of 131I-Tyr). It's high stability was explained by in vitro stability experiments and molecular docking. A new PSMA-targeted radioiodinated drug, [125/131I]IMPA, was synthesized to verify whether compound 8 remained stable after conjugation with drugs. It exhibited a lower thyroid uptake of only 0.19 ± 0.03 %ID, approximately 100-fold lower than that of the control compound [131I]ITPA, which has a tyrosine moiety as the radioiodination site. In conclusion, 8 is a small, easily labeled, and highly stable prosthetic group with promising potential for developing stable radioiodinated drugs and broadening their therapeutic application.
科研通智能强力驱动
Strongly Powered by AbleSci AI